Suppr超能文献

前列腺良恶性区域 T2 弛豫时间与表观弥散系数的相关性及其与周围区容积分数的关系

Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.

机构信息

Cancer Research UK/EPSRC Imaging Centre, Institute of Cancer Research, Sutton, UK.

出版信息

Br J Radiol. 2013 Apr;86(1024):20120469. doi: 10.1259/bjr.20120469. Epub 2013 Feb 20.

Abstract

OBJECTIVE

To establish whether T2 relaxation and apparent diffusion coefficient (ADC) in normal prostate and tumour are related and to investigate the effects of glandular compression from an enlarged transition zone (TZ) on peripheral zone (PZ) T2 and ADC by correlating them with the peripheral zone fractional volume (PZFV).

METHODS

48 consecutive patients prospectively underwent multiecho T2 weighted (T2W) (echo times 20, 40, 60, 80, 100 ms) and diffusion-weighted (b=0, 100, 300, 500, 800 s mm(-2)) endorectal MRI. In 43 evaluable patients, single slice whole PZ, TZ and tumour (focal hypointense signal on T2W images in a biopsy-positive octant) regions of interest were transferred to T2 and ADC maps by slice matching. T2 and ADC values were correlated, and PZ values were correlated with PZFV.

RESULTS

T2 and ADC values were significantly different among groups [T2 mean±standard deviation (SD) PZ, 149±49 ms; TZ, 125±26 ms; tumour, 97±23 ms; PZ vs TZ, p=0.002; PZ vs tumour, p<0.0001; TZ vs tumour, p<0.0001; ADC×10(-6) mm(2) s(-1) mean±SD PZ, 1680±215; TZ, 1478±139; tumour, 1030±205; p<0.0001]. Significant positive correlations existed between T2 and ADC for PZ, TZ, PZ and TZ together, but not for tumour (r=0.515, p<0.0001; r=0.300, p=0.03; r=0.526, p<0.0001; and r=0.239, p=0.32, respectively). No significant correlation existed between PZFV and PZ T2 (r=0.10, p=0.5) or ADC (r=0.03, p=0.8).

CONCLUSION

The correlation between T2 and ADC that exists in normal prostate is absent in tumour. PZ compression by an enlarged TZ does not alter PZ T2 or ADC to affect tumour-PZ contrast.

ADVANCES IN KNOWLEDGE

Microstructural features of tumours alter diffusivity independently of their effects on T2 relaxation.

摘要

目的

探讨正常前列腺和肿瘤的 T2 弛豫时间和表观扩散系数(ADC)之间是否存在相关性,并通过与周围区(PZ)分容积(PZFV)相关联,研究增大的移行区(TZ)对周围区(PZ)T2 和 ADC 的腺体压迫的影响。

方法

48 例连续患者前瞻性接受多回波 T2 加权(T2W)(回波时间 20、40、60、80、100ms)和扩散加权(b=0、100、300、500、800s/mm(-2)) 直肠内 MRI。在 43 例可评估的患者中,通过切片匹配将单个切片全 PZ、TZ 和肿瘤(活检阳性八分位数中局灶性低信号 T2W 图像)感兴趣区转移到 T2 和 ADC 图谱上。对 T2 和 ADC 值进行相关性分析,并对 PZ 值与 PZFV 进行相关性分析。

结果

各组间 T2 和 ADC 值存在显著差异[PZ 平均±标准偏差(SD)T2,149±49ms;TZ,125±26ms;肿瘤,97±23ms;PZ 与 TZ,p=0.002;PZ 与肿瘤,p<0.0001;TZ 与肿瘤,p<0.0001;ADC×10(-6)mm(2) s(-1)平均±SD PZ,1680±215;TZ,1478±139;肿瘤,1030±205;p<0.0001]。PZ、TZ、PZ 和 TZ 之间的 T2 和 ADC 之间存在显著正相关,但肿瘤之间不存在相关性(r=0.515,p<0.0001;r=0.300,p=0.03;r=0.526,p<0.0001;r=0.239,p=0.32)。PZFV 与 PZ T2(r=0.10,p=0.5)或 ADC(r=0.03,p=0.8)之间无显著相关性。

结论

正常前列腺中 T2 和 ADC 之间的相关性在肿瘤中不存在。增大的 TZ 对 PZ 的压迫不会改变 PZ T2 或 ADC,从而影响肿瘤-PZ 对比度。

知识进展

肿瘤的微观结构特征改变了扩散性,而与它们对 T2 弛豫的影响无关。

相似文献

2
Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
J Magn Reson Imaging. 2016 Jan;43(1):138-48. doi: 10.1002/jmri.24974. Epub 2015 Jun 27.
4
What is the most effective tool for detecting prostate cancer using a standard MR scanner?
Magn Reson Med Sci. 2013 Dec 25;12(4):271-80. doi: 10.2463/mrms.2012-0054. Epub 2013 Oct 29.
8
Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Eur J Radiol. 2019 Sep;118:138-146. doi: 10.1016/j.ejrad.2019.07.009. Epub 2019 Jul 10.
10
Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Abdom Radiol (NY). 2021 Nov;46(11):5369-5376. doi: 10.1007/s00261-021-03221-6. Epub 2021 Jul 22.

引用本文的文献

1
Quantitative magnetic resonance imaging in prostate cancer: A review of current technology.
World J Radiol. 2024 Oct 28;16(10):497-511. doi: 10.4329/wjr.v16.i10.497.
2
Quantitative Prostate MRI, From the Special Series on Quantitative Imaging.
AJR Am J Roentgenol. 2024 Oct 2. doi: 10.2214/AJR.24.31715.
5
Multicenter Repeatability and Reproducibility of MR Fingerprinting in Phantoms and in Prostatic Tissue.
Magn Reson Med. 2022 Oct;88(4):1818-1827. doi: 10.1002/mrm.29264. Epub 2022 Jun 17.
6
MR fingerprinting of the prostate.
MAGMA. 2022 Aug;35(4):557-571. doi: 10.1007/s10334-022-01012-8. Epub 2022 Apr 13.
7
Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
Br J Radiol. 2022 Mar 1;95(1131):20210479. doi: 10.1259/bjr.20210479. Epub 2021 Aug 20.
8
Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies.
Korean J Radiol. 2021 Aug;22(8):1332-1340. doi: 10.3348/kjr.2020.1362. Epub 2021 May 20.

本文引用的文献

2
Advancements in MR imaging of the prostate: from diagnosis to interventions.
Radiographics. 2011 May-Jun;31(3):677-703. doi: 10.1148/rg.313105139.
3
Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Radiology. 2011 Jun;259(3):775-84. doi: 10.1148/radiol.11102066. Epub 2011 Mar 24.
4
Accelerated T2 mapping for characterization of prostate cancer.
Magn Reson Med. 2011 May;65(5):1400-6. doi: 10.1002/mrm.22874. Epub 2011 Mar 10.
5
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.
Eur Urol. 2011 Jun;59(6):962-77. doi: 10.1016/j.eururo.2011.02.034. Epub 2011 Feb 23.
7
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
FEBS J. 2010 Oct;277(19):3904-23. doi: 10.1111/j.1742-4658.2010.07800.x. Epub 2010 Aug 31.
8
Clinical prostate T2 quantification using magnetization-prepared spiral imaging.
Magn Reson Med. 2010 Oct;64(4):1155-61. doi: 10.1002/mrm.22492.
9
Clinical and imaging tools in the early diagnosis of prostate cancer, a review.
JBR-BTR. 2010 Mar-Apr;93(2):62-70. doi: 10.5334/jbr-btr.121.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验